Research and Clinical Trials
The Section of Urology is aligned with the Thayer School of Engineering at Dartmouth in the development of new technologies designed to more accurately image malignant changes in the prostate.
- Drs. Seigne and Halter were engaged in an NIH-funded Challenge Grant to develop a prostate biopsy needle capable of receiving electrical impedance images at the time of prostate biopsy.
- Dr. Pais has completed a number of stone related projects including studies on the use of ultrasonography in the management of ureteral calculi and the role of 24-hour urinary risk factors in stone disease. He recently received external funding to evaluate the role of endogenous urinary thiosulfate in stone formation in pregnancy.
- Dr. Seigne is developing a care pathway to insure that patients with superficial bladder cancer receive post-resection intravesical chemotherapy.
- The Section of Urology, in collaboration with our Dartmouth-Hitchcock Medical Center (DHMC) pediatric colleagues, present at the NEAUA (New England Section of the American Urological Association) and have manuscripts accepted by major journals.
A clinical trial is a research study in which people can participate. The purpose of a clinical trial is to study the effectiveness of a treatment, medication, experimental drug, or device.
There are diverse clinical trials for benign and malignant urological conditions that are enrolling at Dartmouth-Hitchcock and the Norris Cotton Cancer Center. This list is regularly being updated. Please contact the office if you have questions about a particular trial, or would like to schedule an appointment to learn about options.
See the Norris Cotton Cancer Center website for additional urological oncology trials.